Thierry Lefèvre

Showing 1-20 of 69 articles

Coronary interventions

Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study

Asano T, Kogame N, Onuma Y, Modolo R, Chichareon P, Lefèvre T, Legutko J, Digne F, Morel M, Serruys P, Gil R

September 24, 2019 | 10.4244/EIJ-D-19-00361

Percutaneous coronary intervention for obstructive bifurcation lesions: the 14th consensus document from the European Bifurcation Club

Banning A, Flensted Lassen J, Burzotta F, Lefèvre T, Darremont O, Hildick-Smith D, Louvard Y, Stankovic G

May 20, 2019 | 10.4244/EIJ-D-19-00144

EuroCTO Club 2018 meeting: “Experts Live” in Toulouse

Boudou N, Avran A, Garbo R, Lefèvre T, Hildick-Smith D, Reifart N, Galassi A, Mattesini A, Dini C, Brilakis E, Yamane M, Sianos G, Mashayekhi K, Karmpaliotis D, DeMartini T, Werner G, Di Mario C

April 5, 2019 | 10.4244/EIJV14I18A319

Coronary interventions

Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs

Onuma Y, Katagiri Y, Burzotta F, Holm N.R., Amabile N, Okamura T, Mintz G, Darremont O, Flensted Lassen J, Lefèvre T, Louvard Y, Stankovic G, Serruys P

February 7, 2019 | 10.4244/EIJ-D-18-00391

Intravascular ultrasound in the evaluation and treatment of left main coronary artery disease: a consensus statement from the European Bifurcation Club

Mintz G, Lefèvre T, Flensted Lassen J, Testa L, Pan M, Singh J, Stankovic G, Banning A

July 20, 2018 | 10.4244/10.4244/EIJ-D-18-00194

Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club

Burzotta F, Flensted Lassen J, Banning A, Lefèvre T, Hildick-Smith D, Chieffo A, Darremont O, Pan M, Chatzizisis Y, Albiero R, Louvard Y, Stankovic G

May 20, 2018 | 10.4244/EIJ-D-18-00357

Coronary interventions

Intravascular Ultrasound in the Evaluation and Treatment of Left Main Coronary Artery Disease: A consensus statement from the European bifurcation club (EBC)

Banning A, Mintz G, Lefèvre T, Flensted Lassen J, Testa L, Pan M, Singh J, Stankovic G

April 24, 2018 | 10.4244/EIJ-D-18-00194

STEMI

Characteristics of stent thrombosis in bifurcation lesions analysed by optical coherence tomography

Bechiri M, Souteyrand G, Lefèvre T, Trouillet C, Range G, Cayla G, Derimay F, Mangin L, Meneveau N, Caussin C, Motreff P, Amabile N

April 6, 2018 | 10.4244/EIJ-D-17-00794

Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club

Ormiston J, Kassab G, Finet G, Chatzizisis Y, Foin N, Mickley T, Chiastra C, Murasato Y, Hikichi Y, Wentzel J, Darremont O, Iwasaki K, Lefèvre T, Louvard Y, Beier S, Hojeibane H, Netravali A, Wooton J, Cowan B, Webster M, Medrano-Gracia P, Stankovic G

February 2, 2018 | 10.4244/EIJ-D-17-00270

Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club

Flensted Lassen J, Burzotta F, Banning A, Lefèvre T, Darremont O, Hildick-Smith D, Chieffo A, Pan M, Holm N.R., Louvard Y, Stankovic G

January 19, 2018 | 10.4244/EIJ-D-17-00622

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Interventions for valvular disease

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Coronary interventions

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein AP, Mohr F, Colombo A, Feldman T, Morice M

September 20, 2017 | 10.4244/EIJ-D-16-00991

Coronary interventions

In memoriam Alfonso Medina Fernandez-Aceituno, MD, 1946-2017

Pan M, Banning A, Burzotta F, Chatzizisis Y, Chieffo A, Darremont O, Ferenc M, Hildick-Smith D, Flensted Lassen J, Lefèvre T, Louvard Y, Stankovic G

June 20, 2017 | 10.4244/EIJV13I3A41

Coronary interventions

The interventional cardiologist of the 3rd millennium

Lefèvre T

April 7, 2017 | 10.4244/EIJV12I18A356

Coronary interventions

Chronic total coronary occlusion treated by percutaneous coronary intervention: long-term outcome in patients with and without diabetes

Sanguineti F, Garot P, O’Connor S, Watanabe Y, Spaziano M, Lefèvre T, Hovasse T, Benamer H, Unterseeh T, Chevalier B, Morice M, Louvard Y

February 3, 2017 | 10.4244/EIJ-D-15-00278

Interventions for valvular disease

A multicentre European registry to evaluate the Direct Flow Medical transcatheter aortic valve system for the treatment of patients with severe aortic stenosis

Naber C, Pyxaras S, Ince H, Frambach P, Colombo A, Butter C, Gatto F, Hink U, Nickenig G, Bruschi G, Brueren G, Tchétché D, den Heijer P, Schillinger W, Scholtz S, Van der Heyden J, Lefèvre T, Gilard M, Kuck K, Schofer J, Divchev D, Baumgartner H, Asch F, Wagner M, Latib A, De Marco F, Kische S

December 9, 2016 | 10.4244/EIJ-D-15-00511

Interventions for valvular disease

Five-year haemodynamic outcomes of the first-generation SAPIEN balloon-expandable transcatheter heart valve

Sawaya F, Kappetein AP, Wisser W, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Wimmer-Greinecker G, Serruys P, Lefèvre T

August 20, 2016

Coronary interventions

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S-J, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C

August 5, 2016 | 10.4244/EIJV12I5A102

Interventions for valvular disease

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

Vahanian A, Urena M, Walther T, Treede H, Wendler O, Lefèvre T, Spence M, Redwood S, Kahlert P, Rodés-Cabau J, Leipsic J, Webb J

June 10, 2016 | 10.4244/EIJV12I2A37

Latest news

New issue

EHRA/EAPCI consensus on LAA occlusion, EAPCI Position paper on defining device sucess and more

(3D volume-rendered CCTA LAA example)

January 17, 2020

Editorial

From Paris to Amsterdam: EuroPCR, ESC 2020 and spotlight on “The Cutting Edge of Cardiology”

Robert Byrne

January 17, 2020

JAA

New this week: Comparing OFR & FFR, Provisional bifurcation stenting procedure and more

January 21, 2020

TRIALS BOOK

Access some of the latest Trials: EXCEL 5 years, GALILEO, ISAR-REACT 5 ...

(The Trials book is supported by Biotronik)

January 15, 2020

Guidance Papers

Guidelines, consensus & position papers

April 9, 2019

Editorial

The role of the Heart Team in the planning of aortic valve replacement

January 15, 2020

JAA

Last week's JAA's: Inferior caval valve implantation for severe tricuspid regurgitation

Thierry Lefèvre

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke